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Background: Strategic Functional-level planning should be aligned with business level and other functional
strategies of a company. It is presumed that assimilating the strategies could have positive contribution to business
performance, in this regard alignment between marketing strategy and financial strategy seems to be the most
important strategies being studied. An empirical work in generic pharmaceutical manufacturing companies for
evaluating effect of alignment between these two functions on organizational performance was developed in this
paper.
Methods: All Iranian pharmaceutical generic manufactures listed in Tehran stock market have been tested for
period of five years between 2006–2010 and their marketing strategies were determined by using Slater and Olson
taxonomy and their financial strategies have been developed by calculating total risk and total return of sample
companies for five years based on rate of risk and return in the frame of a 2 × 2 matrix. For the business
performance three profitability indices including Q-Tubin (Rate of market value to net asset value), ROA (Return on
Asset), ROE (Return on Equity) have been tested. For analysis, a series of one-way ANOVAs as a collection of
statistical models within marketing strategies considering financial strategy as independent variable and the three
performance measures as dependent variables was used.
Results: Results show strategic alignment between financial and marketing has significant impact on profitability of
company resulting in arise of all three profitability indices. Q tubing’s rate were 2.33,2.09,2.29,2.58 and rate of ROA
were 0.21,0.194,0.25,0.22 and rate of ROE were 0.44,0.46,0.45,0.42 for matched strategy types, respectively the rates
shown here are more than average meaning that specific type of marketing strategy is fitted with specific type of
financial strategy.
Conclusion: Managers should not consider decisions regarding marketing strategy independently of their financial
strategy.
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Intense competition in an increasingly global environ-
ment has triggered renewed interest in the marketing
function which its contribution can make competitive
success to a company and this is possible if an appropri-
ate matching exists between marketing and other func-
tional activities of company.* Correspondence: Aarabi@samaresearch.com
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distribution, and reproduction in any mediumIn particular, it has been supposed that aligning finan-
cial and marketing strategies can make a company
more productive and profitable. However, it has been
discussed about aligning the functions of companies in
recent years in both academic and trade publications
[1-3], but little empirical researches have been
conducted to determine effects of this alignment within
industry defining how marketing strategies and financial
strategies should support each other.
The results of an empirical work to determine the
effect of alignment between marketing and financialed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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in this paper reporting that this empirical work exists
within a sample of Iran’s pharmaceutical manufacturing
companies.
Strategic planning in theory
Within an organization, strategies can be viewed at three
levels as shown in Figure 1. These three levels of strategy
from a hierarchy implies a top-down approach to strat-
egy formulation. However, the three levels overlap and
influence one another which they should be aligned with
each other horizontally and vertically.
The development of strategies consisting of two dis-
tinct constituents can be thought: content and process.
The content of strategy refers to the choices, plans and
actions making up the strategy, but the strategy process
are the act of formulating strategy, analysis, organization
and implementation issues [4].
It has been focused on financial and marketing
alignment and its contribution for organizational
performance in pharmaceutical generic manufacturing
companies.
Marketing strategy
Marketing strategy is the set of integrated decisions and
actions, [5] by which a company wants to recognize and
meet customer needs in order to achieve marketing
goals [6,7].Figure 1 The strategy hierarchy.Marketing strategy is concerned with activities relating
to context analysis at Macro and Micro level, competitor
and customer analysis, segmentation, targeting, and
defining an appropriate positioning based on marketing
mix: product, price, place and promotion decisions [8-10].
The Concept of strategic marketing planning is based
on the assumption that an organization should have a
long-term outlook that is not only environmentally sensi-
tive but also nationally and globally oriented. Therefore,
when an organization develops its strategic policy it must
go beyond its short or mid-term goals and must integrate
feedback from stakeholders and customers to reach its
goals and objectives bringing about benefit not only for
the organization but also for consumers and society.
Hual and Madu (1994) presented four types of market-
ing strategies to reach a totality of strategic marketing
orientation: Volunteer marketing, Total marketing, Value
marketing and Environmentally conscious marketing [11].
Kotler (1991) presented a model of three types of mar-
keting strategic orientation:External marketing, Internal
marketing and Interactive marketing and explained how
they are applied in today’s market place [12].
Hooley, Lyneh & Jobber [13] developed 5 types of
marketing strategies for generic markets by extend the
work by Porter [14] and Miles and Snow [15] by focus-
ing on a wide range of marketing variables. They called
as: Aggressors, Premium positioning segmentors, Stuck-
in-the middlers, High value segmentors and Defenders.
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strategies with a comprehensive study of clustering market-
ing activities. They called their presented types of market-
ing strategies as: Aggressive Marketers, Mass Marketers,
Marketing Minimizers and Value Marketers [16].
They defined this taxonomy according to difference of
each type in following activities: market research, seg-
mentation, product line breath, product innovation,
product quality, customer service, premium pricing, se-
lective distribution, advertising, internal sales force and
support to promotion process [16].
In this study taxonomy of Slater and Olson has been
represented for main purpose of defining types of mar-
keting strategies in pharmaceutical sample companies.
Financial strategies
West (2003) presented four type of financial strategies based
on cost and revenue. He examined four financial strategies:
(1) Uniform cost cuts (2) Selective cost reductions (3) In-
creased operational efficiencies and (4) Cost avoidance by
shifting responsibilities to external parties [17].
Financial strategies are such a suitable frameworks of
decision making dedicated to managers for increasing
expected return and reducing cost and risk to meet
organizational objectives.
As risk and return are two main factors in financial
decision making, in this study four types of financial
strategies based on required return and perceived risk,
were perused. According to risk-return line, based on ac-
cepted risk, the required return will be changed
expecting that with increase of accepted risk the return
of company should be increased [18].
We named four types of financial strategies as:
1) Risk Accepting Strategy (RAc).
2) Conservative Strategy inclined to Risk Avoidance
(CRAv).
3) Risk Avoidance Strategy (RAv).
4) Conservative Strategy inclined to Risk Accepting
(CRAv).Figure 2 Conceptual model of alignment between marketing and finaAccording to the rate of risk and return, different
financial strategies should be selected for a company,
consequently decisions about main financial activities in-
cluding Investment, Providing financial resource, cash
flow and dividing of profit will be different as well.
Organizational performance
In order to evaluate organizational performance, in this
study three indices of Q-tubin, ROA and ROE were used
that according to formulas shown in below and make
use of extracted data from financial statements of com-
panies these indices were calculated [19].
Qtubin ¼ Equity Market Valueþ Liabilities Market Valueð Þ
Equity Book Valueþ Liabilities Book Valueð Þ
ROA ¼ Net Incomeþ Interest expenseð Þ
Average assets during the period
ROE ¼ Net Income
shareholder equity
In this study strategic management theories are
brought into the field of marketing and finance and put
forward a model as shown in Figure 2, which explores
the relationship between strategic alignment in field of
marketing and financing with organizational perform-
ance. According to this model the following hypothesis
were proposed:
Alignment between marketing strategies and financial
strategies is positively related to organizational
performance and promote profitability
The study
As explained earlier, in this study Slater and Olson tax-
onomy for defining of marketing strategies type of sam-
ple companies was used. , they presented four types of
marketing strategies as follow:ncial strategies.
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the segment of buyers who prefer high quality, innova-
tive products and who are willing to pay premium
prices. They reach this selected group of buyers with a
very selective distribution strategy, and invest in adver-
tising and marketing support activities.
Mass Marketers, that offer a broad line of largely un-
differentiated product. They utilize an intensive distribu-
tion strategy and charge low price.
Marketing Minimizers, which put comparatively little
effort into marketing activity and provide lowest level of
services for customer. In this type of strategy there are
limited line of product, small amount of investment in
marketing and innovation and prices are comparatively
low, so it indicates that marketing is not a key factor in
their value chains [14,15,20].
Value Marketers, in this type of strategy firms utilize
selective distribution channel to provide high quality
and innovative products with significantly lower prices
in comparison to aggressive marketers. They usually use
their own sales forces instead of advertising to commu-
nicate their value proposition.Measurements
The sample of this study indicates all Iranian pharmaceut-
ical companies listed in Tehran stock market including 30
generic pharmaceutical manufacturing companies that
provide more than 60 percent of Iran’s pharmaceutical
market needs. In this regard, a period of five years between
2006–2010 were selected, which means 150 years
assessing for defining of types of their strategies. Based on
Slater and Olson study and considering nature of pharma-
ceutical marketing a questionnaire for determining strat-
egies of marketing was developed as it is stated in
Appendix, for adjusting questionnaire with pharmaceut-
ical marketing an interview with 40 marketing managers
or marketing experts who were involved in generic medi-
cines marketing was done.
Financial strategies were defined by measuring of total
risk and total return based on date reported in annually
financial statements of companies and then performance










Figure 3 Diagram of financial strategy types based on risk and returnthe years study was being done, data was collected from
financial reports as well.
Marketing strategies
Marketing strategies were assessed using the Slater and
Olson taxonomy by using the prepared questionnaire.
To fill out the questionnaire, five marketing managers
who had more than five years work experiences in the
sample companies were selected from each company
and the questionnaires were completed with face to face
interview or on the phone, then for bias reduction the
results of some respondents were submitted to another
person to cross checking.
Financial strategies
For assessing financial strategies, total risk and total re-
turn as two strategic reference points for sample com-
panies during the five years were determined, then
average rate of risk and return of whole Iran’s pharma-
ceutical industry as the middle point were assigned and
then the type of strategies was found based on the rate
of total risk and total return (Figure 3).
As shown in Figure 3, if the rate of total risk and total
return be more than the average rate of these indices in
industry, the type of strategy would be Risk Accepting
(RAc), if the total risk be more than average rate and
total return be lower than it, then the strategy would be
Conservative inclined to Risk Accepting (CRAc), also if
total risk be lower than average rate and total return be
more than it, the strategy type would be Conservative
inclined to Risk Avoidance (CRAv); finally if both total
risk and total return be lower than average rate, the
strategy would be Risk Avoidance (RAv).
Performance
Business performance is a complex and multi–faceted
concept. In this study, three financial indicators including
Q-tubin, ROA, ROE indices were used to assess profitabil-
ity and market added value of sample Companies.
The average of industry was defined as middle point
and the rate above average as good performance and the
rate below average as weak performance were measured,
respectively.Risk accepting
(RAc)
Conservative inclined to Risk 
accepting
(CRAc)
isk                                     high        
.
Mohammadzadeh et al. DARU Journal of Pharmaceutical Sciences 2013, 21:65 Page 5 of 7
http://www.darujps.com/content/21/1/65Validity and reliability
For the validity testing of questionnaire, content validity
with assessing of comprehensiveness, relevance and clar-
ity of each question based on pharmaceutical marketing
experts’ opinion was evaluated.
For the reliability evaluation, Cronbakh’s alpha coeffi-
cient for each question was calculated, and then by
modifying the text and form of items, rate of coefficient
to minimum 0.77 was achieved.Analysis
To assess the benefit of alignment between financial
strategy and marketing strategy types, a series of one-
way ANOVA software within marketing strategies were
used, for that, financial strategy as independent variable
and the three performance measures as dependent vari-
ables, were used. The least significant difference test to
detect significant differences (at p < 0.05) between finan-
cial strategy types within each marketing strategy type
was applied. T-tests to perform pairwise companies be-
tween all groups means were applied for those least sig-
nificant differences were used as well.Findings
The results of this analysis, as shown in Table 1 are quite
compelling. Indeed, these results indicate strong support
the effect of matching strategies on profitability indices.
As shown in Table 1 all three performance indices are
significantly higher in matched strategy types, it means
special pairwise strategy types indicate higher range of
profitability.Table 1 Performance implications of the match between mark
Q-tubin RA
Aggressive marketing 2.33 (0.54) 1.
Marketing minimizer 1.64 (0.36) 2.
Mas marketing 1.66 (0.42) 1.
Value marketing 2.11 (0.42) 2.
ROA RA
Aggressive marketing 0.21 (0.07) 0.
Marketing minimizer 0.08 (0.02) 0.1
Mas marketing 0.11 (0.04) 0.
Value marketing 0.10 (0.02) 0.
ROE RA
Aggressive marketing 0.44 (0.10) 0.
Marketing minimizer 0.36 (0.11) 0.
Mas marketing 0.39 (0.08) 0.
Value marketing 0.32 (0.06) 0.
Means performance value/S.D.
Financial strategy type differences into marketing strategy type. The bold numbersDiscussion
Strategies in all levels within the organization should be
compiled and support each other regarding the thorough
goals existing in the organization to creating synergy. In
spite of the fact that design and compile of strategy within
an organization is essential with top-down or bottom-up
approach, objectives, operations and the method for
implementing. The top level strategies should be reflected
in bottom levels and for this purpose the strategies of all
levels must be matched or aligned with together. Through
this, functional levels have very essential role in developing
strategic coordination. Along this, each of the functional
sectors have to had relevancy with each other even hori-
zontally and vertically and this is in a way that activity of
them causes reinforcement of the others resulting im-
provement of the organization’s performance. Marketing
as brain of the company exists to find needs and wants of
customer to meet them and achieve satisfaction of cus-
tomer to maintain and develop market. On the other hand
financing sector exist to organize providing of essential
resources for organization, developing the investment
provision and development and restraining the excess
costs and exploitation of resources in the organization.
Marketing unit has to investigate the current situation of
the financial unit before acting for designing the plans. In
this study, marketing and financial strategies have been di-
vided into four different types and the specific definition
of them for the purpose of alignment assessment has been
represented; in this case, the obtained results show that
each of the marketing strategies is relevant with financial
strategy and specific pairwise strategies cause more per-
formance for organization, so based on results the four
below propositions can be reported.eting strategy and financial strategy
CRAv RA CRAc
84 (0.38) 1.63 (0.36) 1.76 (0.34)
09 (0.28) 1.74 (0.35) 1.43 (0.29)
72 (0.34) 2.29 (0.41) 1.82 (0.36)
09 (0.46) 2.18 (0.44) 2.58 (0.62)
CRAv RA CRAc
10 (0.03) 0.12 (0.03) 0.15 (0.04)
94 (0.05) 0.11 (0.03) 0.09 (0.04)
07 (0.02) 0.25 (0.08) 0.13 (0.03)
14 (0.03) 0.15 (0.04) 0.22 (0.05)
CRAv RA CRAc
34 (0.08) 0.37 (0.08) 0.35 (0.07)
46 (0.09) 0.38 (0.08) 0.34 (0.07)
32 (0.06) 0.45 (0.11) 0.35 (0.08)
34 (0.07) 0.37 (0.09) 0.42 (0.08)
show the higher performance of matched strategy types.
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superior performance in case of utilizing a Risk
Accepting financial strategy.
Proposition 2. Mass Marketers will achieve superior
performance in case of utilizing a Risk Avoidance
financial strategy. Results have shown that most of the
pharmaceutical companies which are active in field of
generic products use mass marketing and risk
avoidance strategies for marketing and financing.
Perhaps having similar forms and name for products
across the market trigger decisions of this type.
Proposition 3. Marketing Minimizer will achieve more
performance in case of utilizing a Conservative inclined
to Risk Avoidance financial strategy.
Proposition 4. Value Marketers will achieve superior
performance in case of utilizing a Conservative inclined
to Risk Accepting financial strategy.
While the results from this study support the propos-
ition that generic pharmaceutical manufactures that have
internally consistent plans for marketing and financial
strategies are more profitable than those without
consistency, there may be other factors influencing this
relationship. Perhaps future research could investigate
the relationship between other functional strategies like
human resources, information system and operation
with marketing and financial strategies.Conclusion
Generic pharmaceutical product marketing is one of the
domains within pharmaceutical marketing with high com-
petitiveness in designing, compiling and implementing the
strategy relevant with objectives and the situation of the
market. Managers in the field of both generic and ethical
pharmaceutical marketing have to be informed of the fact
that decision making and determining the strategy in any
level of the organization have to be aligned with higher
and/or lower levels. As the results of this study illustrates
the role of financial strategy in the marketing strategy
decision and it means that managers should not consider
decisions regarding marketing strategy independently of
their financial strategy.Appendix
Question: According to the years mentioned below, which
of the following options offers the best description of the
marketing strategy of your company? Please check the
box beside each option (year) which matches to the de-
scription most.
Each option can be determined for one year or more
yet for each year one option (strategy) can be selected. In
other words, strategy can be the same for different years
but for one year you cannot select 2 strategies.1. Our company proceeds with creative activities and
presenting new products of high quality, having
a close relationship with customers including
prescribers, patients, influencers,(KOL) key opinion
leaders, and retailors. The company has carried out a
widespread marketing research in order to find
opportunities, threats, as well as analyzing customers
and competitors and try to present the products
with prestigious prices. Our distributing strategy is
selective, therewith those customers and/or markets
which are able to afford at high stand are targeted.
Professional and efficient marketing staff are
employed. We vary our products frequently and
support a large number of scientific and medical
incidents and conferences for physicians, and
pharmacists. 2006? 2007? 2008? 2009? 2010?
2. Our company presents the products of appropriate
quality and performs as follower for innovation and
product development. A widespread channel of
distribution is applied for distributing of products. We
compete by using of lower price and financial
encouragement instead of advertising and professional
marketing. We put emphasis on promotion of the sale
of our present products more than its diversity and
differentiation. Besides, a number of the marketing
staff work to establish a relationship with customers.
2006? 2007? 2008? 2009? 2010?
3. Preceding the presentation of the products to the
market, our company waits for it to see if the
concept of product is accepted by the customers, in
this way we decrease the risk. We manage our
market through the accepted quality, lower price
and strategy of widespread distribution. We highly
focus on the production lines and pursuit the
productive and low cost production. We mostly take
the benefit of sales staff rather than the marketing
ones. 2006? 2007? 2008? 2009? 2010?
4. Our company presents the products of high quality and
innovative. Establishing a close relationship with the
customers including influencers, Key Opinion Leaders,
retailors (pharmacies) to value creation. The company
performs less systematic marketing strategy and hardly
turns to products with high value, prestigious pricing, or
high affordable markets. Distributing strategy is not
totally selective or global yet something in between.
Advertising and marketing is taken into account
moderately. 2006? 2007? 2008? 2009? 2010?
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